Medgene Labs is an animal health diagnostics and therapeutic development company working with researchers and strategic partners in the fields of virology, bacteriology, immunology, and molecular diagnostics. The company?'s products include an air sampling system that is used by producers to collect porcine reproductive and respiratory syndrome virus and other airborne pathogens; and instruments, assays, and reagents, which detect infectious pathogens in the air and in the biological samples of animals. Working with researchers and strategic partners in the fields of virology, bacteriology, immunology, and molecular diagnostics, these market-aligned technology concepts include an expanding network of university researchers, regional producers, biotechnology companies and contract research organizations. Medgene Labs has developed a proprietary in-vitro system for the production of monoclonal antibodies, including human monoclonal antibodies using cultured follicular dendritic cells, which eliminates the need to infect or immunize animals for patients to produce the antibodies. The company's initial vaccine formulation target is Rift Valley Fever, a USDA and NIH Priority Target critical to national defense and a major health challenge in developing countries.
